ResearcherAffiliated Hangzhou First People's Hospital, Westlake University, School of MedicineActive in the last 2 years

Li Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2663-965X. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2025: 1 paper

Papers 1

Ph-triazole as a therapeutic agent for pancreatic cancer: Synthesis, in silico, and in vitro evaluation. Last author DOI 10.1371/journal.pone.0334618 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xingxing Li · 1 shared paper, 2025 · strength 0.30
- Paper Ph-triazole as a therapeutic agent for pancreatic cancer: Synthesis, in silico, and in vitro evaluation. DOI 10.1371/journal.pone.0334618 ↗
Ningbo Zhang · 1 shared paper, 2025 · strength 0.30
- Paper Ph-triazole as a therapeutic agent for pancreatic cancer: Synthesis, in silico, and in vitro evaluation. DOI 10.1371/journal.pone.0334618 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.